Skip to content

Clinical trials

Completed Thyroid Cancer, Papillary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Status: Completed Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20044
20051
20063
20074
20082
20102
20112
20125
20131
20142
20152
20171
20181
20202
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Massachusetts General Hospital3
Academic and Community Cancer Research United2
Exelixis2
Memorial Sloan Kettering Cancer Center2
University of Washington2
Bhavana Konda1
Famewave Ltd.1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary43
Thyroid Neoplasms30
Adenocarcinoma, Follicular27
Carcinoma, Medullary12
Carcinoma, Non-Small-Cell Lung8
Head and Neck Neoplasms7
Colonic Neoplasms5
Pancreatic Neoplasms5
Salivary Gland Neoplasms5
Thyroid Carcinoma, Anaplastic5

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.